Literature DB >> 32273479

Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.

Shamzah Araf1, Koorosh Korfi2, Findlay Bewicke-Copley2,3, Jun Wang3, Sergio Cogliatti4, Emil Kumar2, Flavio Forrer5, Sally F Barrington6, Trevor A Graham7, David W Scott8, Lisa M Rimsza9, Andrew Davies10, Peter Johnson10, Jessica Okosun2, Jude Fitzgibbon11, Martin Fehr12.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32273479      PMCID: PMC7271579          DOI: 10.3324/haematol.2019.242206

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

Authors:  Madhavi Challa-Malladi; Yen K Lieu; Olivia Califano; Antony B Holmes; Govind Bhagat; Vundavalli V Murty; David Dominguez-Sola; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

2.  Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Authors:  David W Scott; George W Wright; P Mickey Williams; Chih-Jian Lih; William Walsh; Elaine S Jaffe; Andreas Rosenwald; Elias Campo; Wing C Chan; Joseph M Connors; Erlend B Smeland; Anja Mottok; Rita M Braziel; German Ott; Jan Delabie; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Timothy C Greiner; Betty J Glinsmann-Gibson; Kai Fu; Louis M Staudt; Randy D Gascoyne; Lisa M Rimsza
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

3.  PyClone: statistical inference of clonal population structure in cancer.

Authors:  Andrew Roth; Jaswinder Khattra; Damian Yap; Adrian Wan; Emma Laks; Justina Biele; Gavin Ha; Samuel Aparicio; Alexandre Bouchard-Côté; Sohrab P Shah
Journal:  Nat Methods       Date:  2014-03-16       Impact factor: 28.547

4.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.

Authors:  Michael R Green; Andrew J Gentles; Ramesh V Nair; Jonathan M Irish; Shingo Kihira; Chih Long Liu; Itai Kela; Erik S Hopmans; June H Myklebust; Hanlee Ji; Sylvia K Plevritis; Ronald Levy; Ash A Alizadeh
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

5.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

6.  Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Authors:  Anupama Reddy; Jenny Zhang; Nicholas S Davis; Andrea B Moffitt; Cassandra L Love; Alexander Waldrop; Sirpa Leppa; Annika Pasanen; Leo Meriranta; Marja-Liisa Karjalainen-Lindsberg; Peter Nørgaard; Mette Pedersen; Anne O Gang; Estrid Høgdall; Tayla B Heavican; Waseem Lone; Javeed Iqbal; Qiu Qin; Guojie Li; So Young Kim; Jane Healy; Kristy L Richards; Yuri Fedoriw; Leon Bernal-Mizrachi; Jean L Koff; Ashley D Staton; Christopher R Flowers; Ora Paltiel; Neta Goldschmidt; Maria Calaminici; Andrew Clear; John Gribben; Evelyn Nguyen; Magdalena B Czader; Sarah L Ondrejka; Angela Collie; Eric D Hsi; Eric Tse; Rex K H Au-Yeung; Yok-Lam Kwong; Gopesh Srivastava; William W L Choi; Andrew M Evens; Monika Pilichowska; Manju Sengar; Nishitha Reddy; Shaoying Li; Amy Chadburn; Leo I Gordon; Elaine S Jaffe; Shawn Levy; Rachel Rempel; Tiffany Tzeng; Lanie E Happ; Tushar Dave; Deepthi Rajagopalan; Jyotishka Datta; David B Dunson; Sandeep S Dave
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

7.  Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Authors:  Roland Schmitz; George W Wright; Da Wei Huang; Calvin A Johnson; James D Phelan; James Q Wang; Sandrine Roulland; Monica Kasbekar; Ryan M Young; Arthur L Shaffer; Daniel J Hodson; Wenming Xiao; Xin Yu; Yandan Yang; Hong Zhao; Weihong Xu; Xuelu Liu; Bin Zhou; Wei Du; Wing C Chan; Elaine S Jaffe; Randy D Gascoyne; Joseph M Connors; Elias Campo; Armando Lopez-Guillermo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Kevin Tay Kuang Wei; Andrew D Zelenetz; John P Leonard; Nancy L Bartlett; Bao Tran; Jyoti Shetty; Yongmei Zhao; Dan R Soppet; Stefania Pittaluga; Wyndham H Wilson; Louis M Staudt
Journal:  N Engl J Med       Date:  2018-04-12       Impact factor: 91.245

8.  Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.

Authors:  Elodie Bohers; Pierre-Julien Viailly; Stéphanie Becker; Vinciane Marchand; Philippe Ruminy; Catherine Maingonnat; Philippe Bertrand; Pascaline Etancelin; Jean-Michel Picquenot; Vincent Camus; Anne-Lise Menard; Emilie Lemasle; Nathalie Contentin; Stéphane Leprêtre; Pascal Lenain; Aspasia Stamatoullas; Hélène Lanic; Julie Libraire; Sandrine Vaudaux; Louis-Ferdinand Pepin; Pierre Vera; Hervé Tilly; Fabrice Jardin
Journal:  Blood Cancer J       Date:  2018-08-01       Impact factor: 11.037

9.  Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.

Authors:  Andrew Davies; Thomas E Cummin; Sharon Barrans; Tom Maishman; Christoph Mamot; Urban Novak; Josh Caddy; Louise Stanton; Shamim Kazmi-Stokes; Andrew McMillan; Paul Fields; Christopher Pocock; Graham P Collins; Richard Stephens; Francesco Cucco; Alexandra Clipson; Chulin Sha; Reuben Tooze; Matthew A Care; Gareth Griffiths; Ming-Qing Du; David R Westhead; Catherine Burton; Peter W M Johnson
Journal:  Lancet Oncol       Date:  2019-04-01       Impact factor: 41.316

10.  Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.

Authors:  Jessica Okosun; Csaba Bödör; Jun Wang; Shamzah Araf; Cheng-Yuan Yang; Chenyi Pan; Sören Boller; Davide Cittaro; Monika Bozek; Sameena Iqbal; Janet Matthews; David Wrench; Jacek Marzec; Kiran Tawana; Nikolay Popov; Ciaran O'Riain; Derville O'Shea; Emanuela Carlotti; Andrew Davies; Charles H Lawrie; Andras Matolcsy; Maria Calaminici; Andrew Norton; Richard J Byers; Charles Mein; Elia Stupka; T Andrew Lister; Georg Lenz; Silvia Montoto; John G Gribben; Yuhong Fan; Rudolf Grosschedl; Claude Chelala; Jude Fitzgibbon
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

View more
  2 in total

1.  Radiomic Features of 18F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes.

Authors:  Yeye Zhou; Yuchun Zhu; Zhiqiang Chen; Jihui Li; Shibiao Sang; Shengming Deng
Journal:  Contrast Media Mol Imaging       Date:  2021-11-22       Impact factor: 3.161

2.  Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.

Authors:  Ann-Marie E Bröske; Koorosh Korfi; Anton Belousov; Sabine Wilson; Chia-Huey Ooi; Christopher R Bolen; Marta Canamero; Enrique Gomez Alcaide; Ian James; Emily C Piccione; David J Carlile; Natalie Dimier; Pablo Umaña; Marina Bacac; Martin Weisser; Michael Dickinson
Journal:  Blood Adv       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.